Trial intelligence / Profile preview

Lidoderm 5% Patch in Diabetic Neuropathy

NCT01086150Phase 3Completed

Sponsor
Albany Medical College
Start
Oct 2009
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lidocaine in diabetic peripheral neuropathy (DPN), sponsored by Albany Medical College. Started Oct 2009; status: completed.

02

Drugs

lidocaine
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT01086150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01086150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call